Eliem Therapeutics Inc

NASDAQ:ELYM   1:27:12 PM EDT
3.13
-0.30 (-8.75%)
Earnings Announcements

Eliem Therapeutics Reports Second Quarter Financial Results

Published: 09/13/2021 20:21 GMT
Eliem Therapeutics Inc (ELYM) - Eliem Therapeutics Reports Second Quarter Financial Results.
Eliem Therapeutics - Qtrly Loss per Share $3.11.
Eliem Therapeutics Inc - Cash Was $99.5 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.